Emil Bogenmann

Emil Bogenmann, PhD, is an Associate Professor of Pediatrics at the University of Southern California. His research primarily focuses on pediatric oncology, with an emphasis on neuroblastoma pathogenesis, cancer therapeutics, and molecular mechanisms of cell differentiation. He investigates targeted drug delivery systems, neurotrophin receptor signaling, and genetic models of cancer progression.

Research Interests: Dr. Bogenmann's work spans:

• Molecular pathways in neuroblastoma (RET/TRKA signaling, NGF responsiveness)
• Novel therapeutics like liposomal fenretinide for tumor targeting
• Genetic and epigenetic regulation in pediatric cancers
• Nerve growth factor receptors in cancer aggressiveness

Publications reflect consistent focus on translational neuroblastoma research, with recent expansion into STEM education methodologies during the COVID-19 pandemic.